Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Full article: The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Hemato | Free Full-Text | Renal Disorders Associated with Waldenström Macroglobulinaemia, IgM MGUS and IgM-Producing B-Cell Lymphoproliferative Disorders
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Make the Free Light Change - Siemens Healthineers USA
Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study - ScienceDirect
Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Evolution of kappa, lambda light chain level and kappa/lambda ratio (A)... | Download Scientific Diagram
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
In response to: Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study | Blood Cancer Journal
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Full article: The association of serum-free light-chain levels with markers of renal function
Patients' characteristics according to eGFR > 55 and ≤ 55 ml/min.... | Download Scientific Diagram
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Table 5 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Median (IQR) levels of serum kappa and lambda FLC and FLC ratio in... | Download Scientific Diagram
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
